The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at MUSC have joined forces to create and test an ...

For the first time in his life, a young New Jersey man is pain-free thanks to a new gene treatment working to cure patients ...

The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at the Medical University of South Carolina ...

It has been nearly two years since Pfizer’s sickle cell disease (SCD ... the treatment after an agreement was reached on a price cut. Cost-effectiveness agency NICE has issued final draft ...

Medical experts and cultural leaders in the Lango sub-region have proposed various measures to reduce the financial burden of treating Sickle Cell Disease (SCD), following the withdrawal of USAID ...

HILLSBOROUGH COUNTY, Fla. — There is an incredible story of love and sacrifice out of Plant City that helped to heal a little girl from sickle cell disease. Aliyah Reid spent the first five ...

The center supports individuals living with thalassemia and sickle cell disease by delivering a holistic, patient-centric, and evidence-based model of care ABU DHABI: Under the patronage and in the ...

Sanofi SNY announced that the FDA has granted orphan drug designation to its investigational BTK inhibitor, rilzabrutinib, ...

Background: The Multicenter Study of Hydroxyurea (HU) in Sickle Cell Anemia (MSH) previously showed that daily oral HU reduces painful sickle cell (SS) crises by 50% in patients with moderate to ...

WEST MONROE, La. (KTVE/KARD) — Today on Louisiana Living, Ashley Doughty is joined by Lonnikia Robinson to describe the upcoming Walk-A-Thon. For more information, watch the video above ...

Children with sickle cell disease, a chronic hemolytic anemia, present with a wide variety of neurological syndromes, including ischemic and hemorrhagic stroke, transient ischemic attacks ...

Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...